Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors
Clinical trial NCT03245450 · COMPLETED
Trial details
- NCT number
- NCT03245450
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2021-05-17
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.